Personal information

No personal information available

Activities

Collapse all

Employment (1)

Novartis Pharma AG: Basel, Basel-Stadt, CH

2015-09-15 to present
Employment
Source: Self-asserted source
Paul Wassmann

Works (9)

A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab

Science Translational Medicine
2023-02 | Journal article
DOI: 10.1126/scitranslmed.abq5068
Contributors: Jeffrey D. Kearns; Paul Wassmann; Ufuk Olgac; Marie Fichter; Brigitte Christen; Tina Rubic-Schneider; Stephan Koepke; Benjamin Cochin de Billy; David Ledieu; Cedric Andre et al.
Source: check_circle
Crossref

Pre-Clinical In-Vitro Studies on Parameters Governing Immune Complex Formation

Pharmaceutics
2022-06 | Journal article | Author
DOI: 10.3390/pharmaceutics14061254
Contributors: Marie Fichter; Gesa Richter; Alexander Bepperling; Paul Wassmann
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Stability liabilities of biotherapeutic proteins: Early assessment as mitigation strategy

Journal of Pharmaceutical and Biomedical Analysis
2021-01 | Journal article
DOI: 10.1016/j.jpba.2020.113650
Contributors: Susana A. Lobo; Paulina Bączyk; Brigitte Wyss; Jasmin C. Widmer; Lídia P. Jesus; Joana Gomes; Ana P. Batista; Steffen Hartmann; Paul Wassmann
Source: check_circle
Crossref

Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development

mAbs
2019-11-17 | Journal article
DOI: 10.1080/19420862.2019.1660564
Contributors: Romain Ollier; Paul Wassmann; Thierry Monney; Christelle Ries Fecourt; Sunitha Gn; Vinu C A; Daniel Ayoub; Cian Stutz; Girish S Gudi; Stanislas Blein
Source: check_circle
Crossref

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.

The Journal of biological chemistry
2017-04-27 | Journal article
DOI: 10.1074/jbc.m117.782433
PMID: 28450393
PMC: PMC5465497
Source: Self-asserted source
Paul Wassmann

Crystal structure of Sol I 2: a major allergen from fire ant venom.

Journal of molecular biology
2011-11-12 | Journal article
DOI: 10.1016/j.jmb.2011.10.009
PMID: 22100449
Source: Self-asserted source
Paul Wassmann

Regulatory cohesion of cell cycle and cell differentiation through interlinked phosphorylation and second messenger networks.

Molecular cell
2011-08-01 | Journal article
DOI: 10.1016/j.molcel.2011.07.018
PMID: 21855795
PMC: PMC3298681
Source: Self-asserted source
Paul Wassmann

Structure of BeF3- -modified response regulator PleD: implications for diguanylate cyclase activation, catalysis, and feedback inhibition.

Structure (London, England : 1993)
2007-08-01 | Journal article
DOI: 10.1016/j.str.2007.06.016
PMID: 17697997
Source: Self-asserted source
Paul Wassmann

Activation of the diguanylate cyclase PleD by phosphorylation-mediated dimerization.

The Journal of biological chemistry
2007-07-19 | Journal article
DOI: 10.1074/jbc.m704702200
PMID: 17640875
Source: Self-asserted source
Paul Wassmann
How many people are using ORCID?